EMVISION MEDICAL DEVICES LTD
ASX:EMVHealth Care Equipment & ServicesToday’s holders own 92.0% of what they think they own, once every option and right converts.
Runway 4–8 quarters; share count grew 9% in 24 months; 1 cash raise in 24 months
EMVISION MEDICAL DEVICES LTD's ordinary share count increased by 8.7% between September 2024 and May 2026, reaching 93M shares. In the past 24 months, the company completed one capital raise, a placement and SPP in September 2025, which brought in A$14.0M. Options and rights on issue could convert to 8M new shares, representing 8.7% of the current share count, with the nearest expiry in June 2027; none of these options are currently in the money. As of the June 2026 quarter, the company reported A$14.3M in available cash, covering approximately 4.1 quarters of its operating expenses. There are no proposed securities issues pending.
Shares on issue — last 2 years
Cash runway
Issuance timeline
Latest 5 filings (Appendix 2A quoted issues, 3G unquoted, 3H cancellations)
| Date | Form | Security | On issue, per this filing | Source |
|---|---|---|---|---|
| 11 Sept 2026 | 3G · unquoted | EMV : ORDINARY FULLY PAID | 93.0M | Appendix 3G |
| 11 May 2026 | 2A · quoted issue | EMV : ORDINARY FULLY PAID | 93.0M | Appendix 2A |
| 10 Apr 2026 | 3G · unquoted | EMV : ORDINARY FULLY PAID | 92.9M | Appendix 3G |
| 6 Feb 2026 | 3G · unquoted | EMV : ORDINARY FULLY PAID | 92.9M | Appendix 3G |
| 2 Jan 2026 | 3H · cancellation | EMV : ORDINARY FULLY PAID | 92.9M | Appendix 3H |
Capital raises
1 cash raise in the last 24 months · 1 in the last 12 months
Forward supply
Every dated event on record that could add securities to the register — option expiries to their stated dates and proposed issues over the next 18 months, on one timeline.
Placement capacity
How much stock a company can place without asking holders. Listing Rule 7.1 allows 15% of ordinary securities in any 12 months, and every Appendix 3B states how much of it an issue uses.
Pending proposed issues
Options & convertible securities
- Price-triggered7.4M · 8.0% of sharesOptions and warrants — they convert when the share price clears their exercise price.At least 5.4M of it states no exercise price — that much cannot be called in or out of the money.
- Condition-triggered656k · 0.7% of sharesPerformance and incentive rights — they convert when a hurdle is met, not at a price, and can lapse to nothing.
Exercise price on record: 2.0M priced, 6.1M where the filing never states one. A security with no exercise price is never counted in the money — nothing is paid to convert it, so there is no price for it to be above.
Each figure is the filing’s own count of securities, not a share count — a 2A never states what one security converts into.
An exercise price is on record for only 24.8% of this supply, so what is in the money today is not a measurement — the tile above reads “—” for that reason. Of the priced supply, 0 is in the money at $1.75 today. No more priced supply until 1.5× today’s price, which takes it to 800k (0.9% of shares).
- Priced supply in the money at the price on the axis — the curve, and the only thing on it. Ten prices, sampled: between two of them the true figure lies between the two.
- 6.1M (75.2% of the supply above) states no exercise price at all. It cannot be called in or out of the money at any price, which is why it is hatched rather than plotted.
| Code | Security | Type | Exercise price | Expiry | On issue | Source |
|---|---|---|---|---|---|---|
| EMVAO | Performance rights | Condition-triggered | — | 30 June 2027 | 27k | Filing Meeting |
| EMVO | Options | Price-triggered | — | 3 Nov 2027 | 5.4M | Filing |
| EMVAW | Options | Price-triggered | $3.15 | 31 Dec 2027 | 600k | Filing |
| EMVAU | Performance rights | Condition-triggered | — | 30 June 2028 | 2k | Filing Meeting |
| EMVAAA | Options | Price-triggered | $3.00 | 31 Dec 2028 | 200k | Filing |
| EMVAX | Options | Price-triggered | $2.60 | 11 Feb 2029 | 800k | Filing |
| EMVAV | Performance rights | Condition-triggered | — | 30 June 2029 | 13k | Filing Meeting |
| EMVAA | Options | Price-triggered | $2.68 | 6 Aug 2029 | 400k | Filing |
| EMVAZ | Performance rights | Condition-triggered | — | 30 June 2030 | 32k | Filing Meeting |
| EMVAY | Performance rights | Condition-triggered | — | 11 Aug 2030 | 150k | Filing Meeting |
| EMVAB | Performance rights | Condition-triggered | — | 6 Feb 2031 | 100k | Filing Meeting |
| EMVAC | Performance rights | Condition-triggered | — | 10 Apr 2031 | 60k | Filing Meeting |
| — | Performance rights | Condition-triggered | — | 30 June 2031 | 273k | Filing Meeting |
“Nil” is a stated nil exercise price: nothing is paid to convert. An em dash means the filing names no exercise price at all. Security is read from the filing’s own class description; an em dash there means the description is not one this table labels. One row is one security class, at the number stated in the most recent quotation application that restated it — linked, and dated, in the last column.
A condition-triggered class has no exercise price and usually no expiry: what it vests on is set by a shareholder resolution, not by the register. Where the company lodged a notice of meeting before the class first appears here, it is linked as “Meeting” — that is where terms of this kind are put to shareholders. It is not confirmation that the document sets this class’s conditions, and no link appears where there is no such filing.
Director dealings
| Date | Director | Type | Shares | Options | Other | Value | Source |
|---|---|---|---|---|---|---|---|
| 22 Apr 2026 | Carmel Monaghan | Buy on-market | 10k | 200k | — | $18k | 3Y notice |
| 31 Dec 2025 | Mr John Keep | Sell | — | 300k | — | — | 3Y notice |
| 18 Nov 2025 | Carmel Monaghan | Other | — | 200k | — | — | 3Y notice |
Ownership
Latest announcements
Headlines link to the source PDFs on the ASX announcements platform. Data as of 12 Sept 2026.